Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

"Cardiac arrest-Favorable functional outcome despite high NSE levels and early brain swelling".

Hofer B, Dunzendorfer S, Beer R, Joannidis M.

Resuscitation. 2017 Jul;116:e3. doi: 10.1016/j.resuscitation.2017.04.031. Epub 2017 Apr 26. No abstract available.

PMID:
28456656
2.

Characterization of Microvesicles in Septic Shock Using High-Sensitivity Flow Cytometry.

Lehner GF, Harler U, Haller VM, Feistritzer C, Hasslacher J, Dunzendorfer S, Bellmann R, Joannidis M.

Shock. 2016 Oct;46(4):373-81. doi: 10.1097/SHK.0000000000000657.

PMID:
27206273
3.

Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation.

Hasslacher J, Lehner GF, Harler U, Beer R, Ulmer H, Kirchmair R, Fischer-Colbrie R, Bellmann R, Dunzendorfer S, Joannidis M.

Intensive Care Med. 2014 Oct;40(10):1518-27. doi: 10.1007/s00134-014-3423-4. Epub 2014 Aug 20. Erratum in: Intensive Care Med. 2014 Oct;40(10):1621-2.

PMID:
25138227
4.

Pharmacokinetics of amphotericin B colloidal dispersion in critically ill patients with cholestatic liver disease.

Weiler S, Überlacher E, Schöfmann J, Stienecke E, Dunzendorfer S, Joannidis M, Bellmann R.

Antimicrob Agents Chemother. 2012 Oct;56(10):5414-8. doi: 10.1128/AAC.00690-12. Epub 2012 Jul 30.

5.

Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells.

Bertocchi C, Traunwieser M, Dörler J, Hasslacher J, Joannidis M, Dunzendorfer S.

Cell Physiol Biochem. 2011;28(4):625-30. doi: 10.1159/000335758. Epub 2011 Dec 14.

6.

Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study.

Hasslacher J, Bijuklic K, Bertocchi C, Kountchev J, Bellmann R, Dunzendorfer S, Joannidis M.

Crit Care. 2011 Jul 12;15(4):R166. doi: 10.1186/cc10307.

7.

Influence of albumin dialysis on pharmacokinetics of amphotericin B colloidal dispersion and amphotericin B lipid complex.

Weiler S, Vogelsinger H, Joannidis M, Dunzendorfer S, Bellmann R.

Artif Organs. 2011 Jun;35(6):667-71. doi: 10.1111/j.1525-1594.2010.01111.x. Epub 2011 Feb 14.

PMID:
21668831
8.

Human tissue distribution of voriconazole.

Weiler S, Fiegl D, MacFarland R, Stienecke E, Bellmann-Weiler R, Dunzendorfer S, Joannidis M, Bellmann R.

Antimicrob Agents Chemother. 2011 Feb;55(2):925-8. doi: 10.1128/AAC.00949-10. Epub 2010 Nov 15.

9.

Differential effects of NO inhibition in renal epithelial and endothelial cells in mono-culture vs. co-culture conditions.

Bertocchi C, Schmid M, Hasslacher J, Dunzendorfer S, Patsch JR, Joannidis M.

Cell Physiol Biochem. 2010;26(4-5):669-78. doi: 10.1159/000322334. Epub 2010 Oct 29.

10.

Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials.

Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M.

Crit Care. 2010;14(5):R191. doi: 10.1186/cc9308. Epub 2010 Oct 28.

11.

Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.

Weiler S, Falkensammer G, Hammerer-Lercher A, Anliker M, Vogelsinger H, Joannidis M, Dunzendorfer S, Stein M, Bellmann R.

Antimicrob Agents Chemother. 2009 Nov;53(11):4934-7. doi: 10.1128/AAC.00796-09. Epub 2009 Aug 24.

12.

Levels of amphotericin B lipid formulations in ascites.

Weiler S, Bellmann-Weiler R, Dunzendorfer S, Joannidis M, Bellmann R.

J Antimicrob Chemother. 2008 Nov;62(5):1163-4. doi: 10.1093/jac/dkn306. Epub 2008 Jul 28. No abstract available.

PMID:
18662944
13.

Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.

Schusterschitz N, Bellmann R, Stein M, Dunzendorfer S, Pechlaner C, Joannidis M.

Intensive Care Med. 2008 Jul;34(7):1350-1. doi: 10.1007/s00134-008-1039-2. Epub 2008 Feb 23. No abstract available.

PMID:
18297262
14.

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Lee HK, Dunzendorfer S, Soldau K, Tobias PS.

Immunity. 2006 Feb;24(2):153-63.

15.

Neurokinin-1 receptor interacts with PrP(106-126)-induced dendritic cell migration and maturation.

Kaneider NC, Kaser A, Dunzendorfer S, Tilg H, Patsch JR, Wiedermann CJ.

J Neuroimmunol. 2005 Jan;158(1-2):153-8.

PMID:
15589049
16.

Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity.

Dunzendorfer S, Lee HK, Tobias PS.

Circ Res. 2004 Oct 1;95(7):684-91. Epub 2004 Sep 2.

17.

TLR4 is the signaling but not the lipopolysaccharide uptake receptor.

Dunzendorfer S, Lee HK, Soldau K, Tobias PS.

J Immunol. 2004 Jul 15;173(2):1166-70.

18.

Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses.

Dunzendorfer S, Lee HK, Soldau K, Tobias PS.

FASEB J. 2004 Jul;18(10):1117-9. Epub 2004 May 7.

PMID:
15132988
19.

Increased expression of CCL20 in human inflammatory bowel disease.

Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Mürzl E, Grasl E, Jasarevic Z, Romani N, Offner FA, Tilg H.

J Clin Immunol. 2004 Jan;24(1):74-85.

PMID:
14997037
20.

Heparan sulfate proteoglycans are involved in opiate receptor-mediated cell migration.

Kaneider NC, Dunzendorfer S, Wiedermann CJ.

Biochemistry. 2004 Jan 13;43(1):237-44.

PMID:
14705951

Supplemental Content

Loading ...
Support Center